Skip to main content
Erschienen in: Journal of Neurology 9/2011

01.09.2011 | Original Communication

First report of a pathogenic mutation on exon 24 of the NOTCH3 gene in a CADASIL family

verfasst von: Raffaella Valenti, Silvia Bianchi, Francesca Pescini, Camilla D’Eramo, Domenico Inzitari, Maria Teresa Dotti, Leonardo Pantoni

Erschienen in: Journal of Neurology | Ausgabe 9/2011

Einloggen, um Zugang zu erhalten

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a genetically transmitted small vessel disease clinically characterized by migraine, recurrent subcortical strokes, and cognitive and mood disorders. Pathogenic mutations are located on any of the exons of the NOTCH3 gene coding for epidermal-growth factor (EGF)-like repeats of the extracellular domain of the NOTCH3 receptor. Because the gene is large and the mutations cluster on some exons, many laboratories restrict the analysis to these exons. We report the first missense mutation involving exon 24 and causing CADASIL in a 64-year-old man. The patient was admitted to the hospital for a loss of consciousness accompanied by profuse sweating. On examination, some parkinsonian features were present. Over the last 4 years, he had developed postural instability and gait disturbances with repeated falls, behavioral disorders, and cognitive impairment. A diagnostic hypothesis of atypical parkinsonism had been advanced. The presence of multiple subcortical lacunar infarcts and leukoencephalopathy extended to the external capsule on cerebral MRI suggested the presence of CADASIL. The diagnosis was confirmed by finding a heterozygous mutation leading to a cysteine substitution on exon 24 of the NOTCH3 gene. One proband’s brother, who had progressive gait disturbances, unilateral action tremor and bradykinesia, and an asymptomatic niece also resulted affected. This report underlines that when CADASIL is suspected the genetic analysis should be performed on all the NOTCH3 exons coding for EGF-like repeats including exon 24 and confirms that CADASIL may have heterogeneous phenotypes.
Literatur
1.
Zurück zum Zitat Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cécillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707–710PubMedCrossRef Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cécillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707–710PubMedCrossRef
2.
Zurück zum Zitat Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG (2009) CADASIL. Lancet Neurol 8:643–653PubMedCrossRef Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG (2009) CADASIL. Lancet Neurol 8:643–653PubMedCrossRef
3.
Zurück zum Zitat Singhal S, Bevan S, Barrick T, Rich P, Markus HS (2004) The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 127:2031–2038PubMedCrossRef Singhal S, Bevan S, Barrick T, Rich P, Markus HS (2004) The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 127:2031–2038PubMedCrossRef
4.
Zurück zum Zitat Rufa A, De Stefano N, Dotti MT, Bianchi S, Sicurelli F, Stromillo ML, D’Aniello B, Federico A (2004) Acute unilateral visual loss as the first symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Arch Neurol 61:577–580PubMedCrossRef Rufa A, De Stefano N, Dotti MT, Bianchi S, Sicurelli F, Stromillo ML, D’Aniello B, Federico A (2004) Acute unilateral visual loss as the first symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Arch Neurol 61:577–580PubMedCrossRef
5.
Zurück zum Zitat Choi JC, Kang SY, Kang JH, Park JK (2006) Intracerebral hemorrhages in CADASIL. Neurology 67:2042–2044PubMedCrossRef Choi JC, Kang SY, Kang JH, Park JK (2006) Intracerebral hemorrhages in CADASIL. Neurology 67:2042–2044PubMedCrossRef
6.
Zurück zum Zitat Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M (2004) Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain 127:2533–2539PubMedCrossRef Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M (2004) Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain 127:2533–2539PubMedCrossRef
7.
Zurück zum Zitat Chabriat H, Levy C, Taillia H, Iba-Zizen MT, Vahedi K, Joutel A, Tournier-Lasserve E, Bousser MG (1998) Patterns of MRI lesions in CADASIL. Neurology 51:452–457PubMed Chabriat H, Levy C, Taillia H, Iba-Zizen MT, Vahedi K, Joutel A, Tournier-Lasserve E, Bousser MG (1998) Patterns of MRI lesions in CADASIL. Neurology 51:452–457PubMed
8.
Zurück zum Zitat Pantoni L, Pescini F, Nannucci S, Sarti C, Bianchi S, Dotti MT, Federico A, Inzitari D (2010) Comparison of clinical, familial, and MRI features of CADASIL and NOTCH3-negative patients. Neurology 74:57–63PubMedCrossRef Pantoni L, Pescini F, Nannucci S, Sarti C, Bianchi S, Dotti MT, Federico A, Inzitari D (2010) Comparison of clinical, familial, and MRI features of CADASIL and NOTCH3-negative patients. Neurology 74:57–63PubMedCrossRef
9.
Zurück zum Zitat O’Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS (2001) MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 56:628–634PubMed O’Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS (2001) MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 56:628–634PubMed
10.
Zurück zum Zitat Singhal S, Rich P, Markus HS (2005) The spatial distribution of MR imaging abnormalities in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and their relationship to age and clinical features. AJNR Am J Neuroradiol 26:2481–2487PubMed Singhal S, Rich P, Markus HS (2005) The spatial distribution of MR imaging abnormalities in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and their relationship to age and clinical features. AJNR Am J Neuroradiol 26:2481–2487PubMed
11.
Zurück zum Zitat Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP (1999) The natural history of CADASIL: a pooled analysis of previously published cases. Stroke 30:1230–1233PubMedCrossRef Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP (1999) The natural history of CADASIL: a pooled analysis of previously published cases. Stroke 30:1230–1233PubMedCrossRef
12.
Zurück zum Zitat Dotti MT, Federico A, Mazzei R, Bianchi S, Scali O, Conforti FL, Sprovieri T, Guidetti D, Aguglia U, Consoli D, Pantoni L, Sarti C, Inzitari D, Quattrone A (2005) The spectrum of Notch3 mutations in 28 Italian CADASIL families. J Neurol Neurosurg Psychiatry 76:736–738PubMedCrossRef Dotti MT, Federico A, Mazzei R, Bianchi S, Scali O, Conforti FL, Sprovieri T, Guidetti D, Aguglia U, Consoli D, Pantoni L, Sarti C, Inzitari D, Quattrone A (2005) The spectrum of Notch3 mutations in 28 Italian CADASIL families. J Neurol Neurosurg Psychiatry 76:736–738PubMedCrossRef
13.
Zurück zum Zitat Federico A, Bianchi S, Dotti MT (2005) The spectrum of mutations for CADASIL diagnosis. Neurol Sci 26:117–124PubMedCrossRef Federico A, Bianchi S, Dotti MT (2005) The spectrum of mutations for CADASIL diagnosis. Neurol Sci 26:117–124PubMedCrossRef
14.
Zurück zum Zitat Tikka S, Mykkänen K, Ruchoux MM, Bergholm R, Junna M, Pöyhönen M, Yki-Järvinen H, Joutel A, Viitanen M, Baumann M, Kalimo H (2009) Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain 132:933–939PubMedCrossRef Tikka S, Mykkänen K, Ruchoux MM, Bergholm R, Junna M, Pöyhönen M, Yki-Järvinen H, Joutel A, Viitanen M, Baumann M, Kalimo H (2009) Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain 132:933–939PubMedCrossRef
15.
Zurück zum Zitat Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby AH, Powell JF (2002) Diagnostic strategies in CADASIL. Neurology 59:1134–1138PubMed Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby AH, Powell JF (2002) Diagnostic strategies in CADASIL. Neurology 59:1134–1138PubMed
16.
Zurück zum Zitat Escary JL, Cécillon M, Maciazek J, Lathrop M, Tournier-Lasserve E, Joutel A (2000) Evaluation of DHPLC analysis in mutational scanning of Notch3, a gene with a high G-C content. Hum Mutat 16:518–526PubMedCrossRef Escary JL, Cécillon M, Maciazek J, Lathrop M, Tournier-Lasserve E, Joutel A (2000) Evaluation of DHPLC analysis in mutational scanning of Notch3, a gene with a high G-C content. Hum Mutat 16:518–526PubMedCrossRef
17.
Zurück zum Zitat Bianchi S, Rufa A, Ragno M, D’Eramo C, Pescini F, Pantoni L, Cappelli A, Perretti A, Zicari E, Zolo P, Inzitari D, Dotti MT, Federico A (2010) High frequency of exon 10 mutations in the NOTCH3 gene in Italian CADASIL families: phenotypic peculiarities. J Neurol 257:1039–1042PubMedCrossRef Bianchi S, Rufa A, Ragno M, D’Eramo C, Pescini F, Pantoni L, Cappelli A, Perretti A, Zicari E, Zolo P, Inzitari D, Dotti MT, Federico A (2010) High frequency of exon 10 mutations in the NOTCH3 gene in Italian CADASIL families: phenotypic peculiarities. J Neurol 257:1039–1042PubMedCrossRef
18.
Zurück zum Zitat Kieleczawa J (2006) Fundamentals of sequencing of difficult templates. An overview. J Biomol Tech 17:207–217PubMed Kieleczawa J (2006) Fundamentals of sequencing of difficult templates. An overview. J Biomol Tech 17:207–217PubMed
20.
Zurück zum Zitat McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMed McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMed
21.
Zurück zum Zitat Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270–279PubMedCrossRef Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270–279PubMedCrossRef
22.
Zurück zum Zitat Benamer HT, Grosset DG (2009) Vascular Parkinsonism: a clinical review. Eur Neurol 61:11–15PubMedCrossRef Benamer HT, Grosset DG (2009) Vascular Parkinsonism: a clinical review. Eur Neurol 61:11–15PubMedCrossRef
23.
Zurück zum Zitat Wegner F, Strecker K, Schwarz J, Wagner A, Heinritz W, Sommerer F, Thal DR, Schneider JP, Kendziorra K, Sabri O (2007) Vascular Parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic system. J Neurol 254:1743–1745PubMedCrossRef Wegner F, Strecker K, Schwarz J, Wagner A, Heinritz W, Sommerer F, Thal DR, Schneider JP, Kendziorra K, Sabri O (2007) Vascular Parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic system. J Neurol 254:1743–1745PubMedCrossRef
24.
Zurück zum Zitat Van Gerpen JA, Ahlskog JE, Petty GW (2003) Progressive supranuclear palsy phenotype secondary to CADASIL. Parkinsonism Relat Disord 9:367–369PubMedCrossRef Van Gerpen JA, Ahlskog JE, Petty GW (2003) Progressive supranuclear palsy phenotype secondary to CADASIL. Parkinsonism Relat Disord 9:367–369PubMedCrossRef
25.
Zurück zum Zitat Rice CM, McGuone D, Kurian KM, Love S, Renowden SA, Giffin NJ (2011) Autopsy-confirmed, co-existent CADASIL and multiple system atrophy. Parkinsonism Relat Disord [Epub ahead of print] Rice CM, McGuone D, Kurian KM, Love S, Renowden SA, Giffin NJ (2011) Autopsy-confirmed, co-existent CADASIL and multiple system atrophy. Parkinsonism Relat Disord [Epub ahead of print]
26.
Zurück zum Zitat Lesnik Oberstein SA, Jukema JW, Van Duinen SG, Macfarlane PW, van Houwelingen HC, Breuning MH, Ferrari MD, Haan J (2003) Myocardial infarction in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Medicine (Baltimore) 82:251–256 Lesnik Oberstein SA, Jukema JW, Van Duinen SG, Macfarlane PW, van Houwelingen HC, Breuning MH, Ferrari MD, Haan J (2003) Myocardial infarction in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Medicine (Baltimore) 82:251–256
27.
Zurück zum Zitat Pescini F, Bianchi S, Salvadori E, Poggesi A, Dotti MT, Federico A, Inzitari D, Pantoni L (2008) A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient. J Neurol Sci 267:170–173PubMedCrossRef Pescini F, Bianchi S, Salvadori E, Poggesi A, Dotti MT, Federico A, Inzitari D, Pantoni L (2008) A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient. J Neurol Sci 267:170–173PubMedCrossRef
28.
Zurück zum Zitat Pantoni L, Sarti C, Pescini F, Bianchi S, Bartolini L, Nencini P, Basile AM, Lamassa M, Kalaria RN, Dotti MT, Federico A, Inzitari D (2004) Thrombophilic risk factors and unusual clinical features in three Italian CADASIL patients. Eur J Neurol 11:782–787PubMedCrossRef Pantoni L, Sarti C, Pescini F, Bianchi S, Bartolini L, Nencini P, Basile AM, Lamassa M, Kalaria RN, Dotti MT, Federico A, Inzitari D (2004) Thrombophilic risk factors and unusual clinical features in three Italian CADASIL patients. Eur J Neurol 11:782–787PubMedCrossRef
29.
Zurück zum Zitat Adib-Samii P, Brice G, Martin RJ, Markus HS (2010) Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. Stroke 41:630–634PubMedCrossRef Adib-Samii P, Brice G, Martin RJ, Markus HS (2010) Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. Stroke 41:630–634PubMedCrossRef
Metadaten
Titel
First report of a pathogenic mutation on exon 24 of the NOTCH3 gene in a CADASIL family
verfasst von
Raffaella Valenti
Silvia Bianchi
Francesca Pescini
Camilla D’Eramo
Domenico Inzitari
Maria Teresa Dotti
Leonardo Pantoni
Publikationsdatum
01.09.2011
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 9/2011
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-5983-3

Weitere Artikel der Ausgabe 9/2011

Journal of Neurology 9/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.